Clinical Trial Endpoints for Oncology Studies
Best Overall Response and Time to Response | Download Table
Four Big Trials at ASCO Yield Practice-Changing Data
Overall Response Rate, Progression-Free Survival, and Overall Survival With Targeted and Standard Therapies in Advanced Non–Small-Cell Lung Cancer: US Food and Drug Administration Trial-Level and Patient-Level Analyses | Journal of Clinical Oncology
Frontiers | Investigation of the efficacy and safety of cryoablation and intra-arterial PD-1 inhibitor in patients with advanced disease not responding to checkpoint inhibitors: An exploratory study
Esophageal adenocarcinoma with any component of signet ring cells portends poor prognosis and response to neoadjuvant therapy - ScienceDirect
Response rates Overall response rate and depth of response according to... | Download Scientific Diagram
Immunotherapy 101 - BioCanRx
Study Results | ZYNLONTA® (loncastuximab tesirine-lpyl) Patient Site
Characterization of a Real-World Response Variable and Comparison with RECIST-Based Response Rates from Clinical Trials in Advanced NSCLC | SpringerLink
Overall vs. Progression-Free Survival, Response Rates: Oncology Terminology 101 (by Oster Oncology) - YouTube
Abbreviations: CR, complete response; ORR, objective response rate; PR,... | Download Scientific Diagram
Pathologic Complete Response as a Surrogate Endpoint in Breast Cancer - touchONCOLOGY
Starting with higher-dose prednisone boosts 1-year renal response in lupus nephritis
Dara-KRd and tandem ASCT for patients with high-risk NDMM: Results of the IFM-2018-04 trial
The overall response rate | Download Table
Objective response rate assessment in oncology: Current situation and future expectations
Clinical trial end points relevant to patients and society for rare cancers | Semantic Scholar
Development of an algorithm for evaluating the impact of measurement variability on response categorization in oncology trials | BMC Medical Research Methodology | Full Text
Simplifying the Derivation of Best Overall Response per RECIST 1.1 and iRECIST in Solid Tumor Clinical Studies
Best tumor response and overall response rate (ORR) by disease site (n... | Download Table
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Overall Response Rate, Progression-Free Survival, and Overall Survival With Targeted and Standard Therapies in Advanced Non–Small-Cell Lung Cancer: US Food and Drug Administration Trial-Level and Patient-Level Analyses | Journal of Clinical Oncology
Efficacy endpoints in Oncology
Iovance Biotherapeutics: The Frontier Of Novel Cancer Treatment (NASDAQ:IOVA) | Seeking Alpha
Physical exercise during neoadjuvant chemotherapy for breast cancer as a mean to increase pathological complete response rates: Trial protocol of the randomized Neo-ACT trial | PLOS ONE
